Pregnane X receptor agonists impair postprandial glucose tolerance. (Q42595219)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23588309%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

title

Pregnane X receptor agonists impair postprandial glucose tolerance (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23588309%20AND%20SRC:MED&resulttype=core&format=json

pregnane X receptor agonist

28 February 2020

main subject

0 references

author

Jaana Rysä

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23588309%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Janne Hukkanen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23588309%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

M Buler

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23588309%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

M J Savolainen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23588309%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

H Ruskoaho

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23588309%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

J Hakkola

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23588309%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

language of work or name

English

0 references

publication date

5 March 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23588309%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

28 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23588309%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

93

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23588309%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23588309%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

556-563

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23588309%20AND%20SRC:MED&resulttype=core&format=json

Nuclear receptor PXR, transcriptional circuits and metabolic relevance

28 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.48

Induction of cytochrome P450 enzymes: a view on human in vivo findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.48

Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.48

The roles of nuclear receptors CAR and PXR in hepatic energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.48

Nuclear pregnane X receptor cross-talk with FoxA2 to mediate drug-induced regulation of lipid metabolism in fasting mouse liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.48

Activation of pregnane X receptor by pregnenolone 16 α-carbonitrile prevents high-fat diet-induced obesity in AKR/J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.48

Regulation of cytochrome P450 2C9 expression in primary cultures of human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.48

The effect of liver microsomal enzyme inducing and inhibiting drugs on insulin mediated glucose metabolism in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.48

Coordinate regulation of human drug-metabolizing enzymes, and conjugate transporters by the Ah receptor, pregnane X receptor and constitutive androstane receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.48

Effects of rifampin on the pharmacokinetics and pharmacodynamics of glyburide and glipizide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.48

Rifampin enhances the glucose-lowering effect of metformin and increases OCT1 mRNA levels in healthy participants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.48

Rifampin decreases the plasma concentrations and effects of repaglinide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.48

Effect of rifampin on the pharmacokinetics and pharmacodynamics of gliclazide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.48

Elucidating rifampin's inducing and inhibiting effects on glyburide pharmacokinetics and blood glucose in healthy volunteers: unmasking the differential effects of enzyme induction and transporter inhibition for a drug and its primary metabolite

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.48

Rifampicin seems to act as both an inducer and an inhibitor of the metabolism of repaglinide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.48

effect of OATP1B transporter inhibition on the pharmacokinetics of atorvastatin in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.48

Ligand-activated pregnane X receptor interferes with HNF-4 signaling by targeting a common coactivator PGC-1alpha. Functional implications in hepatic cholesterol and glucose metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.48

Resolution of insulin-requiring diabetes after cessation of chemotherapy for tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.48

Tuberculosis and diabetes mellitus: convergence of two epidemics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.48

Activation of nuclear receptor CAR ameliorates diabetes and fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.48

The constitutive androstane receptor is an anti-obesity nuclear receptor that improves insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.48

Effect of CAR activation on selected metabolic pathways in normal and hyperlipidemic mouse livers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.48

Dysglycaemias and fluoroquinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.48

Human nuclear pregnane X receptor cross-talk with CREB to repress cAMP activation of the glucose-6-phosphatase gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.48

A novel pregnane X receptor-mediated and sterol regulatory element-binding protein-independent lipogenic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.48

Nuclear receptors CAR and PXR cross talk with FOXO1 to regulate genes that encode drug-metabolizing and gluconeogenic enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.48

GLUT2 mutations, translocation, and receptor function in diet sugar managing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.48

Pyruvate dehydrogenase kinase regulatory mechanisms and inhibition in treating diabetes, heart ischemia, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.48

Pregnane X receptor and constitutive androstane receptor at the crossroads of drug metabolism and energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.48

Statins and the risk of new-onset diabetes: a review of recent evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.48

The burden of diabetes and hyperlipidemia in treated HIV infection and approaches for cardiometabolic care

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.48

The statin class of HMG-CoA reductase inhibitors demonstrate differential activation of the nuclear receptors PXR, CAR and FXR, as well as their downstream target genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.48

Coactivator PGC-1alpha regulates the fasting inducible xenobiotic-metabolizing enzyme CYP2A5 in mouse primary hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.48

A PCR primer bank for quantitative gene expression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.48

Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.48

Energy-sensing factors coactivator peroxisome proliferator-activated receptor γ coactivator 1-α (PGC-1α) and AMP-activated protein kinase control expression of inflammatory mediators in liver: induction of interleukin 1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.48

Increased insulin requirement in a patient with type 1 diabetes on rifampicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.48

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/CLPT.2013.48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23588309%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference